SCHEMBL20201747

SCHEMBL20201747

Cc1coc(OCC2CC2)c1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.35
CHRNB2 P17787 2/20 0.34
CHRNA5 P30532 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
PARP15 Q460N3 2/20 0.34
PARP10 Q53GL7 2/20 0.34
PARP2 Q9UGN5 1/20 0.34
ADORA2A P29274 1/20 0.33
BRD4 O60885 1/20 0.33
CREBBP Q92793 1/20 0.33
CNR2 P34972 3/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
RIPK1 Q13546 1/20 0.33
PDE4B Q07343 5/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21325074 0.77 CNR2 (0.36) HCAR2PARP15PARP10PARP2CNR2
SCHEMBL20208335 0.70 ADORA2A (0.38) PARP15PARP10PARP2ADORA2ABRD4
SCHEMBL20204747 0.69 CHRNB2 (0.67) HCAR2CHRNB2CHRNA5CHRNB4CHRNA3
SCHEMBL16727170 0.68 LMNA (0.47) PARP15PARP10PARP2RIPK1
SCHEMBL14943724 0.67 HTR1A (0.42) PARP15PARP10RIPK1
SCHEMBL20207973 0.67 PARP15 (0.39) HCAR2PARP15PARP10BRD4CREBBP
SCHEMBL20204753 0.67 HMBS (0.37) HCAR2PARP15PARP10PARP2BRD4
SCHEMBL21350240 0.64 PARP15 (0.36) PARP15PARP10PARP2ADORA2ABRD4
SCHEMBL20201749 0.64 CHRNB2 (0.48) HCAR2CHRNB2CHRNA5CHRNB4CHRNA3
SCHEMBL8930160 0.64 PARP15 (0.55) PARP15PARP10PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098206-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 WO disclosed